Table 3.
Kits | Positive in case | Positive in control | Sensitivity (95%CI) | Specificity (95%CI) |
---|---|---|---|---|
A_IgM | 41 (9) | 8 (122) | 82.00% (69.20%,90.23%) | 93.85% (88.33%,96.85%) |
A_IgG | 43 (7) | 4 (126) | 86.00% (73.81%,93.05%) | 96.92% (92.36%,98.80%) |
B_IgM | 13 (37) | 8 (122) | 26.00% (15.87%,39.55%) | 93.85% (88.33%,96.85%) |
B_IgG | 43 (7) | 28 (102) | 86.00% (73.81%,93.05%) | 78.46% (70.63%,84.66%) |
C_IgM | 31 (19) | 3 (127) | 62.00% (48.15%,74.14%) | 97.69% (93.44%,99.21%) |
C_IgG | 44 (6) | 3 (127) | 88.00% (76.20%,94.38%) | 97.69% (93.44%,99.21%) |
D_Ab | 46 (4) | 1 (129) | 92.00% (81.16%,96.85%) | 99.23% (95.77%,99.86%) |